In this month s live webinar, Cardiovascular Impact of Diabetes Meds: Beyond Blood Sugar Benefits, you ll hear panelists discuss which diabetes meds may have cardiovascular (CV) benefits. We ll also review the evidence and discuss the pros and cons of SGLT2 inhibitors (empagliflozin, etc) and GLP-1 agonists (dulaglutide, etc) in patients with or at risk for CV disease.
- Provider:TRC Healthcare-NetCE
- Activity Link: https://trchealthcare.com/login
- Start Date: 2025-02-18 06:00:00
- End Date: 2025-02-18 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: No
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest